0001387131-20-004497.txt : 20200506 0001387131-20-004497.hdr.sgml : 20200506 20200506183812 ACCESSION NUMBER: 0001387131-20-004497 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200504 FILED AS OF DATE: 20200506 DATE AS OF CHANGE: 20200506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rhodes John B CENTRAL INDEX KEY: 0001346251 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36019 FILM NUMBER: 20853995 MAIL ADDRESS: STREET 1: 74 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp. CENTRAL INDEX KEY: 0001430306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261434750 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 509 MADISON AVE. - SUITE 1608 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 1-800-849-7894 MAIL ADDRESS: STREET 1: 509 MADISON AVE. - SUITE 1608 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC. DATE OF NAME CHANGE: 20080320 4 1 ownership.xml OWNERSHIP DOCUMENT X0306 4 2020-05-04 0 0001430306 Tonix Pharmaceuticals Holding Corp. TNXP 0001346251 Rhodes John B C/O TONIX PHARMACEUTICALS HOLDING CORP. 509 MADISON AVENUE, SUITE 1608 NEW YORK NY 10022 1 0 0 0 Stock Option 0.77 2020-05-04 4 A 0 75000 0.00 A 2021-05-04 2030-05-04 Common Stock 75000 75000 D The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. /s/ Jessica Morris, Attorney-in-Fact 2020-05-06